FDA approves first non-opioid pain medicine in more than 20 years
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time in over two decades that the agency has approved a non-opioid pain drug with a novel mechanism of action.
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...
The first comprehensive guidelines dedicated to minimizing infections in patients undergoing surgeries and procedures ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback